Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue
+4.97%
EPS
+731.9%
Free cash flow
+255.6%
Total debt
−9.48%

Quarter to September 2026, against a year earlier

25.57 0.93 −3.51%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
21.3×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.07 0.96 0.76 0.87
P/FCF ratio
10.91 13.52 11.97 29.53
P/Operating CF
22.24 38.68 40.62 16.79
P/B ratio
1.92 1.78 1.44 1.61
EV/Sales
1.64 1.60 1.42 1.54
EV/EBITDA
12.61 12.61 11.13 11.96
EV/FCF
16.74 22.49 22.27 52.15
Current Ratio
1.79 1.95 1.85 2.31
Net Debt/EBITDA
14.28 16.03 24.57 26.26
Debt/Equity
1.33 1.53 1.57 1.55
Earnings Yield
(5.88%) (9.71%) (12.68%) (9.68%)
Free Cash Flow Yield
9.16% 7.39% 8.36% 3.39%
Free Cash Flow per Share
0.87 0.33 0.15 0.87
Book value per Share
12.52 11.95 11.68 11.89
Free Cash Flow
448.00 169.00 76.00 444.00
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026